about
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of ...
Read More
20.70
-0.20
(-0.96%)
17.0M
XNYS Volume
XNYS 08 Jul, 2025 5:30 PM (EDT)
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Kenvue Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..